President Trump’s aggressive tariff policies – including 25% levies on Canadian/Mexican imports and 34% rates on Chinese goods – have injected unprecedented uncertainty into global M&A markets. While January 2025 saw a 21% YoY increase in large deals, recent measures threaten to derail recovery efforts as companies grapple with supply chain redesigns, valuation mismatches, and retaliatory trade actions[1][3][5].
Sector-Specific Fallout
Manufacturing & Automotive: Nissan and Honda have delayed mergers amid 25% steel/aluminum tariffs, while automakers face 10-20% cost increases on components. EY estimates 15-20% EBITDA compression for suppliers reliant on cross-border parts[1][2][9].
Technology: Semiconductor and AI firms face 32-46% tariffs in Asian markets, though domestic data center operators like Equinix report 12% uptick in acquisition talks for localized infrastructure[5][7].
Healthcare: Medtech deals stalled as 25% tariffs on Chinese components erase 8-10% margin buffers. “Integration timelines now require 18-month tariff contingency plans,” notes Foley & Lardner’s M&A practice[10].
Valuation Pressures
- Target company EBITDA multiples compressed 1.5-2.5x in tariff-exposed sectors since February[3]
- 15% of pending deals renegotiated purchase prices post-tariff announcements[8]
- Private equity dry powder hits record $2.9T as funds await clarity[6]
Global Domino Effects
| Region | Impact | Response |
|---|---|---|
| EU | 20% tariffs threaten $28B in U.S. exports | Retaliatory duties on agricultural/tech goods[11] |
| UK | M&A activity up 14% as alternative to EU supply chains | Accelerating domestic manufacturing JVs[2] |
| Asia | 46% tariff on Vietnam sparks 30% factory relocations | Thailand/Malaysia tax incentives for reshoring[5] |
Legal Minefields
Dealmakers now allocate 25-30% of due diligence to tariff exposure analysis, including:
- Force majeure clauses for escalating trade wars[9]
- Material Adverse Change (MAC) definitions covering >10% tariff hikes[3]
- Contingent value rights for post-closing duty adjustments[8]
“We’re seeing deals restructured as asset purchases rather than stock sales to isolate tariff liabilities,” notes Kimberly Smith, Katten’s Global Corporate Chair[8].
Path Forward
While Fitch warns of 0.8% GDP drag from tariffs, opportunistic plays emerge:
- PwC reports 40% increase in distressed asset bids for tariff-hit manufacturers
- Cross-border JVs up 22% as alternative to full acquisitions[2][6]
- Domestic logistics/distribution targets commanding 8-12x EBITDA premiums[7]
As the White House weighs auto tariff exemptions through May 2025, dealmakers brace for prolonged uncertainty. “This isn’t 2018’s temporary skirmish,” cautions EY’s Mitch Berlin. “We’re rewriting global trade rules in real-time during live transactions.”[1][12]
https://www.cfodive.com/news/growing-angst-trump-tariffs-dampen-merger-outlook-deals-dealmaking/741665/, https://www.raconteur.net/finance/trump-tariffs-ma, https://www.nixonpeabody.com/insights/articles/2025/02/14/the-impacts-of-new-tariffs-on-ma-activity, https://time.com/7274160/trump-reciprocal-tariffs-questions-answered-explainer/, https://economictimes.com/news/international/global-trends/trumps-tariff-salvo-sets-off-alarm-on-us-recession-risks-while-stock-markets-bleed/articleshow/119963618.cms, https://www.insurancebusinessmag.com/us/news/mergers-acquisitions/trumps-policies-could-create-mixed-impacts-on-us-manda–liberty-gts-530402.aspx, https://www.datacenterdynamics.com/en/analysis/donald-trump-tariffs-data-centers-liberation-day/, https://katten.com/kimberly-smith-discusses-impact-of-tariffs-on-ma-activity-with-law360, https://www.squirepattonboggs.com/en/insights/publications/2025/04/corporate-insights-us-m-and-a-legal-considerations-surrounding-tariffs, https://www.medtechdive.com/news/trump-medtech-tariffs-m-and-a-deals/735093/, https://www.pbs.org/newshour/economy/a-timeline-of-trumps-tariff-actions-so-far, https://www.pbs.org/newshour/politics/watch-live-trump-announces-broad-tariffs-at-liberation-day-white-house-event, https://www.factcheck.org/2025/04/trumps-misleading-tariff-chart/
Related Posts
Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy
```html Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', 'Helvetica Neue', sans-serif; line-height:...
Coca-Cola Drops Costa Coffee Sale After Private Equity Bids Fall Short: Report
Coca-Cola has scrapped plans to sell its Costa Coffee chain after private equity bids, including from TDR Capital and Bain Capital, fell below the beverage giant's £2 billion valuation...
Toyota Motor Raises Take-Private Offer for Largest Subsidiary to $34 Billion: Strategic Pivot in EV Era
Toyota Motor Corporation has sweetened its **take-private offer** for its biggest subsidiary, **Denso Corporation**, boosting the bid to approximately $34 billion amid intensifying pressure to...
Netflix Reportedly Prepares All-Cash Bid For Warner Bros. As Paramount Turns Up Heat On Takeover Battle
```html Netflix is amending its Warner Bros. Discovery acquisition offer to an all-cash structure, signaling renewed commitment to a deal now valued at approximately $82.7 billion for the company's...